Abstract: The invention relates to solar cells or solar cell modules comprising a layer on or in the front radiation-receiving side of the solar cell comprising effect pigments consisting of a transparent or semi-transparent flake-form substrate coated with one or more layers of transparent or semi-transparent materials and optionally with a post coating, and a process for their preparation.
Type:
Application
Filed:
December 20, 2018
Publication date:
October 22, 2020
Applicant:
Merck Patent GmbH
Inventors:
Marc HUNGER, Johannes TASCH, Cairon PLATZER, Oliver DOLL, Piotr WIERZCHOWIEC, Sebastian BARTH, Laurent DELOUX
Abstract: The present invention relates to a composition for ophthalmological products, to corresponding copolymers and the preparation thereof and to the use thereof for the production of ophthalmic lenses or ophthalmological implants and to these products.
Type:
Application
Filed:
December 18, 2018
Publication date:
October 22, 2020
Applicant:
MERCK PATENT GMBH
Inventors:
Lars DOBELMANN-MARA, Simon HELMSTETTER, Stefan RIEDMUELLER, Martin SCHRAUB
Abstract: The present invention relates to a light-converting material which comprises a luminescent material with semiconductor nanoparticles (quantum materials), where the semiconductor nanoparticles are located on the surface of the luminescent material and the emission from the semiconductor nanoparticles is in the region of the emission from the luminescent material. The present invention furthermore relates to a process for the preparation of the light-converting material and to the use thereof in a light source. The present invention furthermore relates to a light-converting mixture, a light source, a lighting unit which contains the light-converting material according to the invention, and a process for the production thereof.
Abstract: The present invention relates to formulations for the preparation of organic electronic devices (OLEDs) which comprise at least one specific ester solvent containing a non aromatic cycle and at least one organic functional material selected from organic conductors, organic semiconductors, organic fluorescent compounds, organic phosphorescent compounds, organic light-absorbent compounds, organic light-sensitive compounds, organic photosensitisation agents and other organic photoactive compounds, selected from organometallic complexes of transition metals, rare earths, lanthanides and actinides.
Abstract: Compounds of the formula (I), in which R1, R3, Het1 and HET have the meanings given in claim 1, are ATM kinase inhibitors and can be employed, inter alia, for the treatment of cancer.
Abstract: The invention relates to methods of treating cancer in a subject, comprising administering to the subject a therapeutically effective amount of an inhibitor of the interaction between the PD-1 receptor and its ligand PD-L1.
Type:
Grant
Filed:
February 23, 2016
Date of Patent:
October 13, 2020
Assignees:
MERCK PATENT GMBH, PFIZER INC.
Inventors:
Jean-Marie Cuillerot, Anja von Heydebreck, Guojun Yuan
Abstract: The present invention relates to a photosensitive composition, and a color conversion film. The present invention further relates to a use of the photosensitive composition in a color conversion film fabrication process, and to a use of the color conversion film in an optical device. The invention further more relates to an optical device comprising the color conversion film and method for preparing the color conversion film and the optical device.
Type:
Application
Filed:
March 27, 2020
Publication date:
October 8, 2020
Applicants:
Merck Patent GmbH, AZ Electronic Materials (Luxembourg) S.A.R.L.
Abstract: The present invention relates to immunoglobulins that bind ADAMTSS and more in particular to polypeptides, that comprise or essentially consist of one or more such immunoglobulins. The invention also relates to constructs comprising such immunoglobulins, such as immunoglobulin single variable domains (ISVDs) or polypeptides as well as nucleic acids encoding such immunoglobulins or polypeptides; to methods for preparing such immunoglobulins, polypeptides and constructs; to host cells expressing or capable of expressing such immunoglobulins or polypeptides; to compositions, and in particular to pharmaceutical compositions, that comprise such immunoglobulins, polypeptides, constructs, nucleic acids and/or host cells; and to uses of immunoglobulins, polypeptides, constructs, nucleic acids, host cells and/or compositions, in particular for prophylactic and/or therapeutic purposes, such as the prophylactic and/or therapeutic purposes mentioned herein.
Type:
Application
Filed:
June 4, 2018
Publication date:
October 8, 2020
Applicants:
Merck Patent GmbH, ABLYNX NV
Inventors:
Marie-Ange BUYSE, Guy HERMANS, Sven LINDEMANN, Hans GUEHRING, Ralf GUENTHER, Roland KELLNER
Inventors:
Matthew Bleich, Jean-Damien Charrier, Huijun Dong, Steven Durrant, Meredith Suzanne Eno, Gorka Etxebarria I Jardi, Simon Everitt, Damien Fraysse, Ronald Knegtel, Igor Mochalkin, Kiri North, Filippos Porichis, Hui Qiu, Robert Pullin, Pierre-Henri Storck, Heather Clare Twin, Yufang Xiao
Abstract: The use of functionalized polymerizable polyvinyl alcohol as a binder or matrix for a dispersion of nanoparticles, wherein the nanoparticles respectively comprise a polymeric shell and a core containing a liquid crystalline medium. Composites comprising the functionalized polymer and the nanocapsules, methods for preparing the composites and electro-optical devices containing such composites.
Abstract: The present invention relates to the purification of target molecules like recombinant and/or biotherapeutic proteins. Activated carbon can be used to remove leachables and/or extractables resulting from disposable equipment employed in the process.
Type:
Grant
Filed:
October 20, 2015
Date of Patent:
October 6, 2020
Assignee:
Merck Patent GmbH
Inventors:
Romas Skudas, Klaus Adrian, Bianca Edlemann, Sven Andrecht, Wilson Moya
Abstract: The present invention is directed towards isomerically pure 18F-labelled (6S)- or (6R)-5-methyltetrahydrofolate radiopharmaceuticals, wherein the phenyl group within the folate structure, has been replaced by an 18F-labelled N-heterocycle, for use in diagnostic imaging of a cell or population of cells expressing a folate-receptor in vitro or in vivo or for use in monitoring of cancer or inflammatory and autoimmune diseases and therapy thereof.
Type:
Application
Filed:
March 19, 2018
Publication date:
October 1, 2020
Applicant:
Merck Patent GmbH
Inventors:
Rudolf MOSER, Viola GROEHN, Cristina MUELLER, Roger SCHIBLI, Simon AMETAMEY, Silvan BOSS
Abstract: The present application relates to compounds of a formula (I), to the use thereof in organic electroluminescent devices, and to processes for preparing these compounds.
Abstract: Compounds of the formula I, in which Y1 denotes —O— or —CH2—, and the groups R1, L1 to L6 and X1 have the meanings indicated in claim 1. A process for the preparation thereof, and liquid-crystalline media comprising at least one compound of the formula I and electro-optical displays containing a liquid-crystalline medium this type. The compounds of the formula I include, as structural element, a combination of a 1,4-substituted cyclohexene ring besides a dioxane or tetrahydropyran ring and a substituted biphenyl group.
Type:
Application
Filed:
March 17, 2020
Publication date:
September 24, 2020
Applicant:
Merck Patent GmbH
Inventors:
Constanze BROCKE, Katharina LINKE, Sven Christian LAUT
Abstract: The invention relates to a liquid crystal medium comprising one or more dielectrically negative compounds and one or more dielectrically positive compounds, characterized in that the medium as a whole exhibits a dielectrically anisotropy (??) in the range from ?0.25 to +0.25. Furthermore, the invention relates to a method of production of such medium and to the use of such medium in a light modulation element utilizing flexoelectric switching. Moreover, the invention relates to a light modulation element utilizing flexoelectric switching comprising the described medium, to a method of production of such light modulation element, to the use of such light modulation element in electro-optical devices and to these electro-optical devices as such.
Type:
Application
Filed:
November 19, 2018
Publication date:
September 24, 2020
Applicant:
MERCK PATENT GMBH
Inventors:
Simon SIEMIANOWSKI, Rachel TUFFIN, Ian SAGE
Abstract: The present invention relates to methods for performing cell culture by using a solid cell culture media form prepared by a 3D printing process.
Abstract: The invention relates to a polymerisable LC material comprising at least one monoreactive mesogenic compound, at least one di- or multireactive mesogenic compound and pentaerythritol tetrakis(3,5-di-tert-butyl-4-hydroxyhydrocinnamate). Furthermore, the present invention relates also to a method for its preparation, a polymer film with improved thermal durability obtainable from the corresponding polymerisable LC material, to a method of preparation of such polymer film, and to the use of such polymer film and said polymerisable LC material for optical, electro-optical, decorative or security devices.
Type:
Application
Filed:
February 7, 2017
Publication date:
September 17, 2020
Applicant:
MERCK PATENT GMBH
Inventors:
Stephen MULCAHY, lain GARDINER, Jack BRADFORD
Abstract: Disclosed are a liquid-crystalline medium which contains at least one compound of formula IA, and in addition at least one compound of formula CC-n-V and/or CC-V-V1, where the percentage proportion of the compound(s) of formula IA is greater than or equal to the percentage proportion of CC-n-V, and/or the percentage proportion of the compound(s) of formula IA is greater than the percentage proportion of CC-V-V1, where the percentage proportion is based on the liquid-crystalline medium, and the use thereof in active-matrix displays, in particular based on the VA, PSA, PVA, PS-VA, SS-VA, SA-VA, PA-VA, PALC, FFS, PS-FFS, PS-IPS or IPS effect.
Type:
Application
Filed:
June 2, 2020
Publication date:
September 17, 2020
Applicant:
MERCK PATENT GMBH
Inventors:
Harald HIRSCHMANN, Martina WINDHORST, Volker REIFFENRATH